Clinical Trial: Routine Use of Potassium Competitive Acid Blocker vs. Guideline-Directed Gastrointestinal Protection Strategy in Acute Myocardial Infarction

U.S., March 13 -- ClinicalTrials.gov registry received information related to the study (NCT07467213) titled 'Routine Use of Potassium Competitive Acid Blocker vs. Guideline-Directed Gastrointestinal Protection Strategy in Acute Myocardial Infarction' on March 09.

Brief Summary: This study aims to compare the clinical outcomes between routine use of potassium competitive acid blocker (P-CAB) and guideline-directed gastrointestinal (GI) protection strategy in patients with acute myocardial infarction (AMI) undergoing percutaneous coronary intervention (PCI) and being treated with dual antiplatelet therapy (DAPT).

Study Start Date: April 01

Study Type: INTERVENTIONAL

Condition: Acute Myocardial Infarction (AMI) Gastrointestinal Bleeding...